Blacknwell
GB Distillers, Inc — Wyandanch, NY
New York
About Blacknwell
Blacknwell is a vodka brand with origins in New York. According to TTB records, the brand is classified as a vodka product with an alcohol content ranging from 80 to 89 proof. The brand maintains a single distinct product offering currently available through retail channels. TTB label approval records indicate one approved label design on file, with the most recent approval documentation dated to 2025. As a New York-origin spirit, Blacknwell represents the vodka category within the spirits market. The brand's vodka classification places it within the standard proof range for the category, meeting regulatory standards for spirits production and distribution in the United States. Limited public information is available beyond the regulatory documentation maintained by the Alcohol and Tobacco Tax and Trade Bureau, which serves as the authoritative source for brand classification and labeling approval data.
| Label Name | Spirit Type | Status | Approval Date | Producer | |
|---|---|---|---|---|---|
| Blacknwell VODKA 80-89 PROOF | Vodka 80-89 Proof | Approved | 2025-03-07 | GB Distillers, Inc |
Page 1 of 1
Blacknwell at a Glance
Blacknwell has 1 distinct product with 1 total TTB label approvals, including Vodka 80-89 Proof. Labels approved between 2025-03-07 and 2025-03-07. Produced in New York.
All information sourced from public TTB records.
Are you the owner or distributor of Blacknwell?
Claim this brand listing to update information or get featured. Contact [email protected].
Produced At
Gb Distillers, INCRelated Brands
- Svedka also from New York
- Three Olives also from New York
- New Amsterdam also from New York
- Recipe 21 also from New York
- 1911 Established also from New York
- Muscle also makes Vodka 80-89 Proof
- Veil also makes Vodka 80-89 Proof
- Heritage Distilling CO also makes Vodka 80-89 Proof
- Holla also makes Vodka 80-89 Proof
- A.M. Scott Distillery also makes Vodka 80-89 Proof
Related Questions
Browse All Labels
Stay informed
Newsletter coming soon.
Follow us on X for new approvals, launches, and industry intelligence.